Gray Stacey T, Lin Alice, Curry William T, Barker Fred G, Busse Paul, Sanan Akshay, Deschler Daniel G, Lin Derrick T
Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States ; Department of Otology and Laryngology, Harvard Medical School, Boston, Massachusetts, United States.
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
J Neurol Surg B Skull Base. 2014 Apr;75(2):110-6. doi: 10.1055/s-0033-1359306. Epub 2013 Dec 11.
Objective To report complications occurring at least 6 months after completion of treatment for patients with anterior skull base malignancy undergoing anterior craniofacial resection (CFR). Design Retrospective review of medical records of all patients undergoing traditional CFR for treatment of anterior skull base malignancy from 2002 through 2011. Setting Massachusetts General Hospital/Massachusetts Eye and Ear Infirmary Cranial Base Center. Participants Thirty-one consecutive patients who had at least 18 months of follow-up for analysis were reviewed. All patients underwent traditional CFR. A total of 28 patients received postoperative proton beam radiation therapy. Eleven patients received adjuvant chemotherapy. Main Outcome Measures A delayed complication was any complication occurring at least 6 months after the completion of treatment. Results Seventeen patients had delayed complications. Orbital complications were the most common type (13 patients) followed by issues with wound healing (6 patients). The most common orbital complication was epiphora (7 patients). The most common wound complication was a nasocutaneous fistula (5 patients). Conclusions Patients with anterior skull malignancy can develop complications months to years after the completion of treatment. Therefore, it is important to continue to follow and report complications for several years when deciding on the optimal approach for treatment of these patients.
报告接受前颅面切除术(CFR)治疗的前颅底恶性肿瘤患者在治疗结束后至少6个月出现的并发症。
对2002年至2011年期间所有接受传统CFR治疗前颅底恶性肿瘤患者的病历进行回顾性研究。
马萨诸塞州总医院/马萨诸塞州眼耳医院颅底中心。
对连续31例至少随访18个月以进行分析的患者进行了回顾。所有患者均接受了传统CFR。共有28例患者接受了术后质子束放射治疗。11例患者接受了辅助化疗。
延迟并发症是指治疗结束后至少6个月出现的任何并发症。
17例患者出现延迟并发症。眼眶并发症是最常见的类型(13例患者),其次是伤口愈合问题(6例患者)。最常见的眼眶并发症是溢泪(7例患者)。最常见的伤口并发症是鼻皮瘘(5例患者)。
前颅底恶性肿瘤患者在治疗结束后数月至数年可能出现并发症。因此,在决定这些患者的最佳治疗方法时,持续数年随访并报告并发症很重要。